A Sophisticated Vaccine for Infection
Monday, March 1, 2021
Based on dendritic cells, the Nusantara vaccine is deemed too sophisticated for use against the Covid-19 virus. In its country of origin, the dendritic cell-based vaccine is used for personalized cancer treatment.
YETTY Movieta Nency suddenly stopped talking despite previously being willing to explain about the Covid-19 vaccine that has completed its phase 1 clinical trial. The member of the Nusantara vaccine research team now refused to be interviewed, saying that her team has delivered enough clarification. “Central researchers advised that we do not need to accommodate additional interviews for now. Researchers are currently busy working on phase
...
Subscribe to continue reading.
We craft news with stories.
For the benefits of subscribing to Digital Tempo, See More